FOSL1 and triple-negative breast carcinoma: In addition, miR-4516 was identified as a novel oncogene by targeting PTPN14 in glioblastoma (46), and stromal loss of miR-4516 could promote FOSL1-dependent proliferation and malignancy of triple-negative breast cancer (47).